|Generate QR code
Open Access
Subscription Access
SPECTROPHOTOMETRIC APPROACH FOR QUANTITATIVE ANALYSIS OF A NEW TRANSTHYRETIN STABILIZER: TAFAMIDIS
Abstract
The development of simple to use, cost-effective, accurate, and precise UV spectrophotometry is the objective of this study. Validation characteristics such as specificity, linearity, accuracy, precision, limit of detection, limit of quantification, and robustness were evaluated in accordance with ICH Q2(R1) guidelines. The drug was measured to have the maximum absorbance at a wavelength of 310 nm. The solution remains stable for up to 12 h. The equation y = 0.1724x – 0.0443, with an R2 of 0.9995, was used to demonstrate the linear response for tafamidis concentration ranges of 2–12 μg/mL. It was found that the accuracy ranged from 100–103%. The intraday and interday precision for repeatability fell within the acceptable parameters (<2%). The technique’s limit of detection was 0.112 μg/mL and the limit of quantification was 0.34 μg/mL. The proposed validated method can be applied to standard quality control purposes as well as tafamidis analysis in pharmaceutical doses form.
Supporting agencies: The authors are thankful to Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS Deemed to be University, Vile Parle West, Mumbai, India, for providing needful resources to conduct studies.
About the Authors
N. Agarwal
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS Deemed to be University
India
India
Vile Parle West, Mumbai, Maharashtra
R. Patil
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS Deemed to be University
India
India
Vile Parle West, Mumbai, Maharashtra
S. Sharma
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS Deemed to be University
India
India
Vile Parle West, Mumbai, Maharashtra
References
1. C. Tschöpe, Elsanhoury, J. Clin. Med., 11, 2148 (2022).
2. A. Grande-Trillo, C. Baliellas, L. Lladó, C. Casasnovas, J. V. Franco-Baux, L. Gracia-Sánchez, M. Á. Gómez-Bravo, E. González-Vilatarsana, L. Caballero-Gullón, E. Echeverri, J. González-Costello, Am. J. Transplant, 21, 372–381 (2021).
3. M. S. Maurer, J. H. Schwartz, B. Gundapaneni, P. M. Elliott, G. Merlini, M. Waddington-Cruz, A. V. Kristen, M. Grogan, R. Witteles, T. Damy, B. M. Drachman, S. J. Shah, M. Hanna, D. P. Judge, A. I. Barsdorf, P. Huber, T. A. Patterson, S. Riley, J. Schumacher, M. Stewart, M. B. Sultan, C. Rapezzi, N. Eng. J. Med., 379, 1007–1016 (2018).
4. In Brief: Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy, The Medical Letter Inc., https://secure.medicalletter.org/TML-article-1590b. Acc. 28 Jan 2024.
5. S. Nencetti, A. Rossello, E. Orlandini, Chem. Med. Chem., 8, 1617–1619 (2013).
6. https://www.ema.europa.eu/en/medicines/human/EPAR/vyndaqel. Acc. 27 Jan 2024.
7. C. Rapezzi, P. Elliott, T. Damy, J. Nativi-Nicolau, J. L. Berk, E. J. Velazquez, K. Boman, B. Gundapaneni, T. A. Patterson, J. H. Schwartz, M. B. Sultan, M. S. Maurer, JACC Heart Fail., 9,115–123 (2021).
8. K.-R. Lee, J.-W. Jeong, H.-C. Hyun, E. Jang, S. Ahn, S. Choi, S. H. Joo, S. Kim, T.-S. Koo, Xenobiotica, 48, 831–838 (2018).
9. M. Smerikarova, S. Bozhanov, V. Maslarska, Int. J. Appl. Pharm., 14, 14–21 (2022).
10. I. Rappley, C. Monteiro, M. Novais, A. Baranczak, G. Solis, R. L. Wiseman, S. Helmke, M. S. Maurer, T. Coelho, E. T. Powers, J. W. Kelly, Biochemistry, 53, 1993–2006 (2014).
11. M. Smerikarova, S. Bozhanov, V. Maslarska, I. Tournev, J. Chromatogr. Sci., 60, 840–847 (2022).
12. H.-C. Hyun, J.-W. Jeong, H.-R. Kim, J.-H. Oh, J.-H. Lee, S. Choi, Y.-S. Kim, T.-S. Koo, J. Pharm. Biomed. Anal., 137, 90–95 (2017).
13. P. A. Lockwood, V. H. Le, M. T. O’Gorman, T. A. Patterson, M. B. Sultan, E. Tankisheva, Q. Wang, S. Riley, Clin. Pharm. Drug Dev., 9, 849–854 (2020).
14. Int. Conf. on Harmonisation of Technical Requirements for registration of Pharmaceuticals for Human use ICH harmonised tripartite guideline validation of analytical procedures: text and methodology Q2(R1).
Review
For citations:
Agarwal N., Patil R., Sharma S. SPECTROPHOTOMETRIC APPROACH FOR QUANTITATIVE ANALYSIS OF A NEW TRANSTHYRETIN STABILIZER: TAFAMIDIS. Zhurnal Prikladnoii Spektroskopii. 2025;92(1):135.
Views: 53
Email this article 